The current state of hormonal therapy for prostate cancer.

Kenneth J Pienta, Beth A Hellerstedt

Journal: CA: a cancer journal for clinicians 2002;52(3):154-79

PMID: 12018929

Abstract

Androgen deprivation therapy remains a mainstay of treatment for men with prostate cancer. New uses for hormonal therapy, including use in the adjuvant and neoadjuvant setting, are being evaluated. Prevention of the side effects of therapy has led to the development of alternative schedules and therapeutics.

Address: Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA.

DOI: 10.3322/canjclin.52.3.154

Link outs

Free resources

Full Text Sources:

https://onlinelibrary.wiley.com/resolve/openurl?ge...

Medical:

Other Literature Sources:

https://www.lens.org/lens/search/patent/list?q=ref...

Subscription / membership required

Full Text Sources:

http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linko...

MeSH Terms: Androgen Antagonists, Combined Modality Therapy, Cyproterone, Diethylstilbestrol, Drugs, Chinese Herbal, Gonadotropin-Releasing Hormone, Hormones, Humans, Male, Plant Extracts, Prostatic Neoplasms